Gastroenterology

In a somewhat bittersweet result for drugmaker Janssen, a United Kingdom health agency has recommended funding its hepatitis C drug for some patients but not for others.

Increased prevalence of hepatitis C infection among the nation's young is the subject of a new federally funded study underway in New Mexico.

Humira (adalimumab) is now indicated to treat children age 6 years and older with moderately to severely active Crohn's disease who have had an inadequate response to treatment with corticosteroids or immunomodulators.

After conducting a population-based, nationwide cohort study, researchers reported a relationship between inflammatory bowel disease (IBD), especially Crohn's disease (CD), and cervical neoplasia.

A generic version of Gilead Science's hepatitis C drug Sovaldi will be produced in India and sold there and in other poorer countries at what is likely to be a fraction of what it costs in the United States.

As more studies have demonstrated potential therapeutic applications for marijuana, public opinion regarding medical and recreational marijuana use has shifted. One such study recently published in the American Journal of Gastroenterology revealed medical marijuana is potentially beneficial for digestive disorders and gastrointestinal symptoms.

Advances in knowledge surrounding gastrointestinal conditions have paved the way for improvements in Crohn's disease (CD) treatment. To aid clinicians in managing patients with CD, the American Gastroenterological Association (AGA) created a clinical decision tool to effectively guide gastroenterologists throughout their decision-making process.

Researchers are learning more about the ways in which gut microbiota interact with the central nervous system and the role this can play in pain management.

Magnetic resonance is an effective alternative to biopsy for identifying and quantifying fats in the liver, according to results from a study led by a research team at the University of the Basque Country.

Experts have discovered a possible correlation between treatment with isotretinoin and decreased risk of inflammatory bowel disease, according to a study published in the Journal of American Medical Association Dermatology.

Researchers at Beth Israel Deaconess Medical Center (BIDMC) reported that proactive monitoring of dose adjustments of infliximab (IFX), one of the 4 anti-TNF-alpha proteins used to treat inflammatory diseases like Crohn's disease (CD), ulcerative colitis (UC), and inflammatory bowel disease (IBD), could prolong the effectiveness of treatment.

Review by a German commission also found major benefits in patients who had not responded to prior treatment with other medications.

Movantik (naloxegol), an oral peripherally acting mu-opioid receptor antagonist, has been approved by the FDA for the treatment of opioid-induced constipation in adults with chronic non-cancer pain.

Breast feeding can potentially protect premature babies from a toxic gastrointestinal disease, according to a recent study published in in the American Journal of Pathology.

Investigators have found that many autoimmune diseases are implicated in the surge and development of eating disorders, according to a study published in PLoS One.

The makeup of a person's brain chemistry could play a role in their environmental food cues, according to the results of a new study.

A recent study published in Clinical Gastroenterology and Hepatology cites the efficacy and safety of resuming infliximab therapy for inflammatory bowel disease (IBD) patients following a drug holiday.

Neon feces could prove to be a game changer in gastrointestinal cancer testing. Researchers at McMaster University, Hamilton, Ontario, Canada, are developing a new non-invasive stool exam to identify the presence of colorectal cancer.

The anion gap is extremely useful in the detection and analysis of metabolic acidosis and also intoxicants and some hematologic conditions.

Basic intestinal microorganisms influence the HIV virus' attack plan against the immune system, according to a study published in Cell Host & Microbe.

A new study published in the Journal of Clinical Pharmacology suggests poor stomach absorption could potentially decrease the efficacy of autism drugs.

A research team with members at the University of California, Los Angeles (UCLA) has discovered genetic factors involved in a severe form of inflammatory bowel disease (IBS), pediatric ulcerative colitis.

Patients with irritable bowel syndrome experience less effective pain treatments, according to research from the University of Adelaide in Australia.

The end of September will mark the deadline set for hospitals across the country to reach Stage 2 of the Meaningful Use program for the year and that means the clock is ticking for health care professionals around the country to meet the goals set for them.

Researchers at the University of Leicester have developed a highly sensitive "electronic-nose" to identify the infectious bacteria Clostridium difficile that causes diarrhea, stomach cramps, and fever in patients.

Monitoring patients' own intestinal immune responses, researchers at Yale University have identified some of the bacterial culprits driving inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis.

On June 7, 2014, the state of Missouri passed State Bill 716, a piece of legislation creating a new category of health care provider in the state, known as the, "Assistant Physician."

Although previous research has found probiotics can prevent antibiotic-associated diarrhea and Clostridium difficile diarrhea, a study from researchers in the United Kingdom and Germany reported contradicting results.

Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.

The European Commission (EU) has granted Bristol-Myers Squibb's Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.